CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 64 enrolled
Drug / intervention
Placebo +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04495751
NCT04495751Early Ph 1Completed
CompareCT.gov

FOCUS - Pilot Study of Muscadine Grape Extract to Improve Fatigue Among Older Adult Cancer Survivors

Wake Forest University Health Sciences·interventional·Posted Aug 3, 2020·Updated Oct 16, 2025

In Brief

A Early Phase 1 clinical trial evaluating Muscadine grape extract, Placebo, and 3 other interventions for Fatigue. Completed, enrolled 64 participants across 1 site.

Detailed Summary

The purpose of this research is to see if muscadine grape extract improves fatigue in people age 70 and above who have a history of treated cancer and report the symptom of fatigue.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFatigue
CountriesUnited States
CollaboratorsNational Center for Advancing Translational Sciences (NCATS), National Cancer Institute (NCI)

Timeline

Early Ph 1CompletedFinished
202120222023202420252026
First PostedAug 3, 2020
Enrollment StartApr 20, 2021
Primary CompletionAug 26, 2024
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 5.9 years ago

Interventions

Muscadine grape extractdietary

Four pills twice daily

Placebodrug

Four pills twice daily.

Quality of Life Assessmentother

Ancillary studies

Questionnairesother

Ancillary studies

Participant Feedbackother

Ancillary studies